HBV and HCV Account for Nearly Three-Quarters of Global HCC Burden Gastroenterology Advisor 16:20 Wed, 10 Jun
True reactivation versus transient viremia: a retrospective analysis of Hbv reactivation in resolved infection Nature.com 00:36 Wed, 03 Jun
Easl spotlight: Tune-401 advances epigenetic silencing in Hbv BioWorld 16:46 Tue, 02 Jun Article paywall
Virion Therapeutics Reports Progress Towards Hbv Functional Cure with Continued HBsAg Declines, Without Rebound, Up to Two Plus Years, After a Single Vron-0200 Dose, From its Phase 1b Study at Easl 2026 Business Wire (Press Release) 16:31 Fri, 29 May
Precision HBV Data Add Early Support For Direct cccDNA Targeting Approach Scrip Pharma Intelligence 14:47 Thu, 28 May
Brii Bio Presents Late-Breaking Data from Its Phase 2 ensure Study at Easl Congress 2026, Further Supporting the Potential Role of Brii-179 in Achieving Durable Immunological Control of Hbv PR Newswire (Press Release) 12:05 Wed, 27 May
Precision BioSciences Announces New and Late-Breaking Pbgene-Hbv Clinical Data from the eliminate-B Study at European Association for the Study of the Liver Congress 2026 Business Wire (Press Release) 07:31 Wed, 27 May
